NeuroPointDX, the diagnostics division of Stemina Biomarker Discovery, and New York-based Ovid Therapeutics announced today they will team up to identify novel biomarkers of a rare genetic disorder called Angelman syndrome….
Propeller Health announced today it has partnered with Novartis Pharma AG to develop a custom add-on sensor for the Breezhaler inhaler to further improve adherence and care management for people living with COPD…
The Centers for Medicare and Medicaid Services (CMS) is considering including Exact Sciences’ Cologuard in the Medicare Advantage Star Ratings program, the company announced today. “The proposed inclusion of Cologuard in…
Stem Pharm, a biotech startup out of the University of Wisconsin, has received $290,000 from the National Institutes of Health, the university announced today. According to a release, the money…
Story provided by Alex Moe, WisBusiness.com JangoBio is working on a stem cell treatment that could hold the key to halting, and even reversing, the effects of aging. The natural process…
Exact Sciences recently announced its fourth quarter numbers, which included revenues between $34.9 million – $35.4 million and 82,000 completed Cologuard tests, an increase of 142 percent and 114 percent…
Five new members were voted onto the BioForward board of directors, the organization announced today. Serving a 2017-19 term from Madison are Exact Sciences CIO Gary Frings and HealthMyne Chief Strategy…
SHINE Medical Technologies has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement, the company announced…
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent that covers the method of use for CLR 1603 to treat breast, lung, colorectal and prostate cancers as…
Beginning Jan. 1, Exact Sciences’ Cologuard will be included for Humana members, the company announced today. Humana has nearly 10 million beneficiaries and is the nation’s fifth largest commercial insurer. “As demand…
